It is worth that 78 drugs identified that target these hub genes have been not proven to mitigate AD, and no EST1-modulating drugs were detected, suggesting that testing of these agents in AD animal models and development of small-molecule EST1 regulators are potentially productive areas for future research. Here, SULT1E1 is linked to Alzheimer disease.